The Importance of Clinical Trial Diversity

Carlo Hote, head of US Oncology Medical Affairs at AstraZeneca: We have to continue to work to make sure that we are really supporting families as they go through this date. And so we are out of time. This has been an amazing and vitally important conversation. I am pleased to see today with Ricky Farley and Dr. Wells to talk about the importance of clinical trial diversity.